期刊文献+

乳腺浸润性导管癌:钼靶X线表现与雌激素受体水平的关系 被引量:12

Infiltrating Ductal Cancer of the Breast: Correlation between Mammographic Features and Estrogen Receptor Level
下载PDF
导出
摘要 目的 探讨乳腺浸润性导管癌 (IDC)钼靶X线表现与雌激素受体 (ER)水平之间的关系 ,评价根据IDC钼靶X线征象预测ER表达的可行性。资料与方法  181例经乳腺钼靶X线摄影、手术病理证实的IDC ,术后标本经免疫组织化学染色判断ER表达情况 ,将IDC钼靶X线表现中的恶性钙化、毛刺征与免疫组织化学染色所得的ER表达情况进行对比研究。结果  181例IDC中 ,肿块伴毛刺者 85例 ,有钙化者 74例 ;ER阳性者 99例 ,毛刺组ER阳性率与无毛刺组相比有显著性差异 (P <0 .0 1) ,且毛刺组中ER阳性表达更多见于较小癌灶 ;无钙化组ER阳性率较钙化组略高 ,但无统计学意义。结论 IDC中毛刺征与ER表达之间存在相关性 。 Objective To investigate the relationship between the mammographic features and the estrogen receptor (ER) level in infiltrating ductal cancer (IDC) of the breast.Materials and Methods A total of 181 patients with IDC, confirmed by both molybdenum palladium roentgenograph of breast and pathology, was enrolled in this study. ER expression of the mastectomy specimens was determined with immunohistochemical staining technique. The correlation between the malignant calcification and spicule sign seen on mammographs with ER expression was studied.Results Of 181 cases, spicule sign was seen in 85, of which calcification was present in 74, and ER positive expression was seen in 99. Significant difference in ER positive rate existed between lesions with spicule sign and lesions without spicule sign (P<0.01). In the group showing spicule sign, ER positive expression was more frequently seen in patients with small lesions. ER positive rate in lesions without calcifications was slightly higher than that in lesions with calcifications, although no statistically significant difference was found.Conclusion A certain correlation exists between spicule sign and ER expression in patients with IDC. It is feasible to predict ER expression of IDC by molybdenum palladium roentgenographic signs.
出处 《临床放射学杂志》 CSCD 北大核心 2003年第5期390-393,共4页 Journal of Clinical Radiology
关键词 乳腺浸润性导管癌 钼靶 X线表现 雌激素受体 免疫组织化学 Breast cancer Mammography Estrogen receptor
  • 相关文献

参考文献13

  • 1[1]Feig SA. Ductal carcinoma in situ implications for screening mammography. Radiologic Clinics of North America, 2000, 38:653
  • 2江泽飞,宋三泰.乳腺癌辅助内分泌治疗若干问题的新认识[J].中华肿瘤杂志,2001,23(1):81-82. 被引量:28
  • 3[3]Sickles E. Breast imaging: from 1965 to the present. Radiology, 2000, 215:1
  • 4[4]Liberman L, Abramson AF, Squires FB,et al. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR, 1998, 171:35
  • 5[5]Huo Z, Giger ML, Wolverton D,et al. Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection. Med Phys, 2000, 27:4
  • 6[6]Brisson J, Brisson B, Cote G,et al. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev, 2000, 9:911
  • 7何子元,火树尧,徐开野.早期乳腺癌的X线表现(附40例报告)[J].临床放射学杂志,2001,20(1):11-13. 被引量:152
  • 8[8]Evans AJ, Pinder SE, Ellis IO,et al. Correlations betweent the mammographic features of ductal carcinoma in situ (DCIS) and c-erbB-2 oncogene expression. Clin Radiol, 1994, 49:559
  • 9[9]Paradiso A, Mangia A, Barlentta A,et al. Mammography and morphobiologic characteristics of human breast cancer. Tumori, 1993, 79:422
  • 10[10]Le BG, Feillel V, de Latour M,et al. Breast cancer detected by a stellar opacity. Histologic characteristics: 155 cases. Gynecol Obstet Fertil, 2000, 28:798

二级参考文献4

共引文献183

同被引文献115

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部